All In MedTech

Device Trial Radar · NCT05591274

Virtual Reality Technology for Vasectomy Pain Modulation

Modulating Intraoperative Vasectomy Pain Using the SmileyScope Virtual Reality Interface

Last checked: Nov 20, 2026Latest source record: Dec 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

120

Actual

Start

Nov 17, 2022

Primary completion

Mar 28, 2024

Study completion Mar 28, 2024

Sponsor

Lead sponsor
University of MiamiAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 24, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
Male only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will evaluate whether or not wearing a virtual reality (VR) headset reduces pain and anxiety in patients undergoing vasectomy. The headset being used is the SmileyScope virtual reality interface, a device already undergoing study for approval by the U.S. Food and Drug Administration (FDA) to reduce pain and anxiety in patients aged 4 years and older undergoing needle blood draw or injection procedures. In this study, the SmileyScope virtual reality interface is considered an investigational device because it is not yet approved for use in adult males undergoing vasectomy.

Conditions

  • Vasectomy
  • Pain, Postoperative
  • Anxiety Postoperative

Interventions

  • SmileyScope Virtual Reality HeadsetDevice

    The SmileyScope Virtual Reality Headset is a VR headset undergoing study for approval by the U.S. Food and Drug Administration (FDA) to reduce pain and anxiety in patients aged 4 years and older undergoing needle blood draw or injection procedures. Currently, this device has been granted entrance to the FDA Safer Technologies Program. The device comes pre-loaded with either an interactive or static virtual reality scenario.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pre-operative AnxietyTime frame: up to 1 day
  2. Post-operative AnxietyTime frame: up to 1 day
  3. Subjective Pre-operative PainTime frame: up to 1 day

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Desai Sethi Urology Institute, University of Miami Miller School of Medicine

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.